STOCK TITAN

[SCHEDULE 13G] Tango Therapeutics, Inc. Passive Investment Disclosure (>5%)

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Adage Capital Management, L.P. and affiliates report a 7.88% beneficial stake in Tango Therapeutics, Inc. They collectively hold 10,607,924 shares of Tango common stock, with shared voting and investment power and no sole authority reported.

The ownership percentage is based on 134,677,094 Tango shares outstanding as of November 1, 2025, as disclosed in a company registration statement. The investors state the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Tango Therapeutics.

Positive

  • None.

Negative

  • None.

Insights

Adage Capital discloses a sizable 7.88% passive stake in Tango Therapeutics.

Adage Capital Management, L.P., along with Robert Atchinson and Phillip Gross, reports beneficial ownership of 10,607,924 Tango Therapeutics common shares, representing 7.88% of the company’s outstanding stock, with shared voting and dispositive power but no sole authority.

The percentage is calculated using 134,677,094 shares outstanding as of November 1, 2025, as referenced from a Tango registration statement. The investors certify the position is held in the ordinary course of business and not with the purpose or effect of influencing control, indicating a passive institutional holding.

This disclosure identifies Adage as a significant shareholder that can vote and dispose of a meaningful block of shares. Future ownership updates in similar disclosures may clarify whether this position is maintained, increased, or reduced over subsequent reporting periods.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Adage Capital Management, L.P.
Signature:/s/ Robert Atchinson
Name/Title:By: Adage Capital Partners LLC, its General Partner, By: Robert Atchinson, its Managing Member
Date:02/12/2026
Robert Atchinson
Signature:/s/ Robert Atchinson
Name/Title:Robert Atchinson, individually
Date:02/12/2026
Phillip Gross
Signature:/s/ Phillip Gross
Name/Title:Phillip Gross, individually
Date:02/12/2026
Exhibit Information

Exhibit 99.1: Joint Filing Agreement

Tango Therapeutics Inc

NASDAQ:TNGX

TNGX Rankings

TNGX Latest News

TNGX Latest SEC Filings

TNGX Stock Data

1.70B
127.50M
12.26%
109.5%
22.83%
Biotechnology
Pharmaceutical Preparations
Link
United States
BOSTON